Results 31 to 40 of about 3,690 (206)

Difluoromethylornithine rebalances aberrant polyamine ratios in Snyder–Robinson syndrome

open access: yesEMBO Molecular Medicine, 2023
Snyder–Robinson syndrome (SRS) results from mutations in spermine synthase (SMS), which converts the polyamine spermidine into spermine. Affecting primarily males, common manifestations of SRS include intellectual disability, osteoporosis, hypotonia, and
Tracy Murray Stewart   +8 more
doaj   +1 more source

Difluoromethylornithine, a Decarboxylase 1 Inhibitor, Suppresses Hepatitis B Virus Replication by Reducing HBc Protein Levels

open access: yesFrontiers in Cellular and Infection Microbiology, 2020
Current treatments of hepatitis B virus (HBV) are limited to Interferon-alpha or the nucleos(t)ide analogs antiviral therapies, and it is crucial to develop and define new antiviral drugs to cure HBV.
Binli Mao   +7 more
doaj   +1 more source

The polyamine inhibitor alpha-difluoromethylornithine modulates hippocampus-dependent function after single and combined injuries. [PDF]

open access: yesPLoS ONE, 2012
Exposure to uncontrolled irradiation in a radiologic terrorism scenario, a natural disaster or a nuclear battlefield, will likely be concomitantly superimposed on other types of injury, such as trauma.
Susanna Rosi   +5 more
doaj   +1 more source

KLF4 is required for suppression of histamine synthesis by polyamines during bone marrow-derived mast cell differentiation.

open access: yesPLoS ONE, 2020
Mast cells have secretory granules containing chemical mediators such as histamine and play important roles in the immune system. Polyamines are essential factors for cellular processes such as gene expression and translation.
Kazuhiro Nishimura   +10 more
doaj   +1 more source

Viability of parasites treated with HYD and DFMO.

open access: yes, 2020
Viability of parasites treated with HYD and DFMO.
Oluyomi Stephen Adeyemi (6733613)   +6 more
core   +1 more source

Alpha-Difluoromethylornithine, an Irreversible Inhibitor of Polyamine Biosynthesis, as a Therapeutic Strategy against Hyperproliferative and Infectious Diseases

open access: yesMedical Sciences, 2018
The fluorinated ornithine analog α-difluoromethylornithine (DFMO, eflornithine, ornidyl) is an irreversible suicide inhibitor of ornithine decarboxylase (ODC), the first and rate-limiting enzyme of polyamine biosynthesis.
Nicole LoGiudice   +4 more
doaj   +1 more source

Effect of DFMO and spermine supplementation on Dnmt activity.

open access: yes, 2013
DFMO decreased, while spermine supplementation increased Dnmt activity in Jurkat cells. Mean ±standard deviation; n = number of experiments as indicated. no treatment (control): cells cultured in culture medium. DFMO: cells cultured with 3 mM DMFO.
Fumio Konishi (283703)   +2 more
core   +1 more source

Studies on lipidomimetic derivatives of α-difluoromethylornithine (DFMO) to enhance the bioavailability in a

open access: yes, 2014
DFMO, a trypanostatic drug, presents a satisfactory intestinal absorption but its elimination from the blood is rapid so that high doses are necessary to obtain a therapeutic effect.
O. Chauffert   +4 more
core   +1 more source

Effect of DFMO and spermine supplementation on Active Rap-1 protein levels.

open access: yes, 2013
Neither DFMO nor spermine activated Rap-1. negative control: cell lysate treated with GDP. positive control: cell lysate treated with GTP-gamma-S. no treatment: cell lysate with no treatment. DFMO: lysate of cells cultured with 3 mM DMFO.
Fumio Konishi (283703)   +2 more
core   +1 more source

Ornithine Decarboxylase Activity Is Required for Prostatic Budding in the Developing Mouse Prostate. [PDF]

open access: yesPLoS ONE, 2015
The prostate is a male accessory sex gland that produces secretions in seminal fluid to facilitate fertilization. Prostate secretory function is dependent on androgens, although the mechanism by which androgens exert their effects is still unclear ...
Melissa Gamat   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy